Latest news with #medtech
Yahoo
7 hours ago
- Business
- Yahoo
Vizient Reserve Program Expands Supply Assurance to Include IV Fluids in Collaboration With Baxter
IRVING, Texas, July 23, 2025--(BUSINESS WIRE)--Vizient® announced today the expansion of the Vizient Reserve Program to include IV fluids through a strategic partnership with Baxter, a leading global medtech company, to help ensure reliable access to these critical products during times of supply disruption. The program provides participating healthcare organizations with dedicated, on-demand manufacturer inventory, warehoused in the U.S., along with comprehensive support to help safeguard continuity of care. The expansion of Vizient Reserve to include IV fluids reflects a strategic collaboration with Baxter to improve supply assurance within the healthcare supply chain and comes less than a year after Hurricane Helene hit the east coast, temporarily disrupting supply of this critical product. IV fluids—a uniquely complex category due to their essential nature, high utilization, and complex manufacturing requirements—are foundational to patient care. While Baxter's U.S. IV fluids production levels have been restored since the hurricane, the partnership between Vizient and Baxter reflects a deliberate, long-term strategy to promote resiliency and help healthcare providers prepare for and manage the pressures that natural disasters and increased demand have put on the supply of this critical healthcare category. "IV fluids are among the most relied upon therapies in healthcare. We've created a scalable, cost-effective reserve model that enhances resiliency and transparency across the supply chain," said Dan Kistner, senior vice president and general manager, category management & strategic programs, Vizient. "This approach builds on the success of our NES Reserve program in the pharmaceutical space, further demonstrating how Vizient is rethinking traditional sourcing strategies with proactive, purpose-built solutions designed to mitigate supply disruptions and ensure continuity of care." With comprehensive inventory management, transparent reporting and dedicated logistics, the program offers a flexible structure to enable access during supply disruptions and support continuity of care. "At Baxter, we are actively committed to supporting hospitals and health systems navigate any threat to supply continuity," said Cecilia Soriano, global president of Baxter's infusion therapies and technologies business. "Baxter and Vizient's shared commitment to enabling access to life-sustaining therapies is at the heart of this initiative, and we're honored to support Vizient clients in their efforts to build greater supply resilience." The new program builds on the success of Vizient Novaplus Enhanced Supply (NES) Reserve, which provides up to six months of additional dedicated manufacturer inventory for essential medications, and expands the breadth of products available through it—including the first-ever medical-surgery product codes. Since its inception, NES Reserve has fulfilled more than 45,000 requests from over 1,700 facilities, totaling more than 5 million additional units of essential medications. Learn more about IV fluids in the Vizient Reserve Program. About Vizient, Inc. Vizient, Inc., the nation's largest provider-driven healthcare performance improvement company, serves more than 65% of the nation's acute care providers, including 97% of the nation's academic medical centers, and more than 35% of the non-acute market. The Vizient contract portfolio represents $140 billion in annual purchasing volume enabling the delivery of cost-effective, high-value care. With its acquisition of Kaufman Hall in 2024, Vizient expanded its advisory services to help providers achieve financial, strategic, clinical and operational excellence. Headquartered in Irving, Texas, Vizient has offices throughout the United States. Learn more at View source version on Contacts Media ContactNancy Matocha(972)
Daily Telegraph
6 days ago
- Business
- Daily Telegraph
PM witnesses life-changing Cochlear moment in final China engagement
Don't miss out on the headlines from Breaking News. Followed categories will be added to My News. Anthony Albanese has wrapped up his lengthy state visit to China by watching young boy hear for the first time using an Australian-designed implant. The Prime Minister's final official engagement on Thursday was a tour of Cohclear's plant in Chengdu. Mr Albanese has touted Australia's world-leading med tech sector in the Chinese research hub, keen to carve out a big piece of the pie as demand grows on the back of China's exploding middle class. But he has been keen to stress the human benefits to doing business throughout his time in China. 'It must be extraordinary to hear for the first time,' Mr Albanese remarked as he and fiancee Jodie Haydon were shown around the Cochlear facility. 'You are changing lives.' The plant opened in 2020 and follows the same manufacturing process as in Australia. Donning blue personal protective equipment, Mr Albanese and Ms Haydon ventured into a sterile space to inspect the three main Cochlear products. They were also shown a glass-walled room where the products are assembled. The room was 10-times more sterile than a surgical theatre. Mr Albanese was then taken into a private space where he watched the moment a young boy's Cochlear implant was activated. Speaking to media ahead of the tour, he said it would be an 'incredibly proud moment'. Prime Minister Anthony Albanese spruiked Australian technology, including the cochlear impact, on his final official event in China. Picture: NewsWire/ Joseph Olbrycht-Palmer 'The idea that an Australian invention gives someone who has never heard the voice of their mum or dad, brother sister, never heard the sound of airconditioning, to hear sound of the river, the birds tweeting – it's amazing,' Mr Albanese told reporters. 'We should be so proud of what we're doing, and it will be an incredibly proud moment for me this afternoon as Australian Prime Minister, to be able to witness that' He also thanked the boy's family 'who have agreed and … wanted to show the difference that it makes'. After five days of high level meetings and sightseeing in three different cities, Mr Albanese will on Friday fly back to Australia. Originally published as PM watches moment young boy hears for the first time during China trip
News.com.au
6 days ago
- Business
- News.com.au
PM watches moment young boy hears for the first time during China trip
Anthony Albanese has wrapped up his lengthy state visit to China by watching young boy hear for the first time using an Australian-designed implant. The Prime Minister's final official engagement on Thursday was a tour of Cohclear's plant in Chengdu. Mr Albanese has touted Australia's world-leading med tech sector in the Chinese research hub, keen to carve out a big piece of the pie as demand grows on the back of China's exploding middle class. But he has been keen to stress the human benefits to doing business throughout his time in China. 'It must be extraordinary to hear for the first time,' Mr Albanese remarked as he and fiancee Jodie Haydon were shown around the Cochlear facility. 'You are changing lives.' This was incredibly special. Suhang’s cochlear implant was activated, and his parents invited us to witness it. Cochlear is a proud Australian invention, and by sharing our skills and technology we can change lives across the world for the better. Cochlear have now helped… â€' Anthony Albanese (@AlboMP) July 17, 2025 The plant opened in 2020 and follows the same manufacturing process as in Australia. Donning blue personal protective equipment, Mr Albanese and Ms Haydon ventured into a sterile space to inspect the three main Cochlear products. They were also shown a glass-walled room where the products are assembled. The room was 10-times more sterile than a surgical theatre. Mr Albanese was then taken into a private space where he watched the moment a young boy's Cochlear implant was activated. Speaking to media ahead of the tour, he said it would be an 'incredibly proud moment'. 'The idea that an Australian invention gives someone who has never heard the voice of their mum or dad, brother sister, never heard the sound of airconditioning, to hear sound of the river, the birds tweeting – it's amazing,' Mr Albanese told reporters. 'We should be so proud of what we're doing, and it will be an incredibly proud moment for me this afternoon as Australian Prime Minister, to be able to witness that' He also thanked the boy's family 'who have agreed and … wanted to show the difference that it makes'. After five days of high level meetings and sightseeing in three different cities, Mr Albanese will on Friday fly back to Australia.
Independent Singapore
13-07-2025
- Business
- Independent Singapore
‘All MCQs with answers given?' Employee doubts manager's degree and credibility, says he was promoted unfairly
SINGAPORE: An employee at a local med-tech firm has raised concerns online after learning that his foreign manager may have earned his degree under questionable circumstances. In a post on the r/askSingapore forum on Saturday (July 12), the employee shared that his manager recently revealed he 'did not have to attend any classes' to complete his degree programme. 'The school offered something called distance education degree program,' the employee said. 'All he [my manager] had to do was attend the exams, which were in multiple-choice question (MCQ) format, and the answers were provided to him beforehand.' The employee wrote that he found this 'extremely ridiculous,' especially since he knows how difficult it is to earn a degree in Singapore. 'I did not have the luxury to be able to get a degree… But I have friends who slogged years in both local and private universities,' he said. 'Is this normal? Did my manager 'fake' his degree? How is it acceptable to be able to 'cheat' your way through to the extent that a local firm accepts the degree?' The employee also pointed out that the degree was a contributing factor in the manager's promotion, which he felt was unfair. He went on to say that, beyond the questionable qualification, the manager has made his work life difficult. According to him, the manager is disorganised, micromanages staff, and writes emails in such poor English that they are often hard to understand. He also claimed the manager does not respect work-life boundaries. 'For example, work for me ends at 5:30 p.m., but if I walk out of the door at 5:30 p.m., he is not happy,' he said. 'We were also allowed to work from home once a week previously, but he has since removed it.' Unable to change jobs at the moment, the employee turned to the online community for advice. 'What would you do if you were in my shoes? I do not have any intention to ruin his rice bowl,' he said. 'Don't be nice since he's being a bad manager to you.' In the comments section, many Singaporean Redditors urged the employee to take action and report his manager to the authorities. One Redditor suggested going straight to the Ministry of Manpower (MOM), saying, 'There's no point reporting to the company; even if they run a background check, it's going to turn up valid unless it's listed as a degree mill by the local country or Singapore itself.' Another commented, 'If you suspect his degree is fake, you could report this MOM, as it would be kept confidential. You mentioned you do not wish to ruin his rice bowl…why not??? If he is trying to ruin yours, why not do the same to him?' A third remarked, 'Ruin his rice bowl. Please. Don't be nice since he's being a bad manager to you.' Still, not everyone agreed with the idea of reporting the manager. One Singaporean Redditor expressed, 'I think what you should be looking at is how competent your boss's hiring manager and HR processes of your company are and make your own judgement call. If you think your boss is not competent because you can do a better job as a manager, then prove it to your boss's boss through your work and make him look bad. However, if work-life balance is what you are seeking, then I suggest you start searching for a new job.' See also 28yo man earning S$12/h asks, "What other jobs can I apply for?" Penalties for lying about qualifications Lying about qualifications in Singapore is not something to be taken lightly, especially for foreign workers. Under Section 22 of the Employment of Foreign Manpower Act (EFMA), submitting false or misleading educational information to the Ministry of Manpower (MOM) can result in a fine of up to S$20,000, up to two years in jail, or both. Employers can also be penalised. If they know or suspect that a foreign employee has submitted fake qualifications and choose not to report it, they may face a fine of up to S$10,000, up to one year in jail, or both. Read more: Nurse says ex-manager didn't return S$1.5k in approved transport claims, seeks advice on Reddit Featured image by Depositphotos (for illustration purposes only)
Yahoo
09-07-2025
- Business
- Yahoo
Endologix Announces that Scott Huennekens Joins Board of Directors
IRVINE, Calif., July 09, 2025--(BUSINESS WIRE)--Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, is pleased to announce that R. Scott Huennekens has been appointed to the Endologix Board of Directors. Mr. Huennekens is a highly regarded medtech CEO, chairperson, entrepreneur and investor, serving an impressive list of companies. Previously, he led Volcano Corp. (VOLC), a leader in minimally invasive therapy guidance in interventional cardiology, from start-up in 2002 to IPO to its sale to Philips in 2015. He was awarded E&Y's entrepreneur of the year award in 2010 and was recognized by Goldman Sachs in 2016, 2017, & 2018 as one of the 100 most intriguing entrepreneurs at its annual Builders & Innovators conference. Mr. Huennekens graduated magna cum laude with a BS in Business Administration from the University of Southern California and holds his MBA from the Harvard Business School. "We are delighted to announce Scott Huennekens as the newest member of our board. With Scott's extensive background in med-tech as both an operator and board adviser, he will be a valuable asset to the company as we go forward," expressed John Liddicoat, MD, President and CEO of Endologix. About Endologix Endologix LLC is a California-based, global medical device company dedicated to improving patients' lives by providing innovative therapies for the interventional treatment of vascular disease. Endologix's therapeutic portfolio includes a variety of products in various stages of development that are designed to treat diseases that currently have clinically relevant unmet needs. Endologix's commercial products, including the AFX®2 Endovascular AAA System, ALTO® Abdominal Stent Graft System, and the DETOUR™ System, are designed to treat a range of vascular diseases, from abdominal aortic aneurysms to lower limb peripheral vascular disease. Endologix is wholly owned by Deerfield Management, an investment management firm committed to advancing healthcare through investment, information, and philanthropy. The company has offices and manufacturing sites in Irvine, Milpitas and Santa Rosa, California. To learn more about Endologix, please visit View source version on Contacts Media Contact Media inquiries: media@
